Ethics and Compliance in Sales and Marketing

September 2010
Pharmaceutical Representative;Sep2010, Vol. 40 Issue 9, p24
The article discusses ethics and compliance as it applies to sales and marketing in biopharmaceutical industries in the U.S. It notes that ethics and compliance issues significantly affect several activities such as pricing decisions in pharmaceutical sales and marketing. Key aspects of the "Code on Interactions with Healthcare Professionals" by the Pharmaceutical Research and Manufacturers of America (PhRMA) and the ethical obligations to monitor drug safety are also tackled.


Related Articles

  • Supply Chain Management and Prescription Drug Promotions -- A Questionable Business and Ethical Perspective. Patel, Naresh; Ehiobuche, Chris // Business Journal for Entrepreneurs;2011, Vol. 2011 Issue 1, p23 

    The US Pharmaceutical market has grown enormously in the last 20 years, mainly due to the expansion in scale of the overall per person consumption of drugs, advances in research resulting in more drug related cures of diseases in lieu of alternate methods or surgical solutions and consumer...

  • Product names, proper claims? More ethical issues in the marketing of drugs. Holm, Soren; Evans, Martyn // BMJ: British Medical Journal (International Edition);12/21/96, Vol. 313 Issue 7072, p1627 

    Analyzes the explicit or implicit claims embodied in the proprietary names of pharmaceutical products. Classification of pharmaceutical trade names; List of drugs with allusive names,its generic constituents, indications and actions or effects suggested by its name; Ways on how to detect drug...

  • The Pharmaceutical Research and Manufacturers of America (PhRMA), Amicus Curiae. Calia, Kurt G. // Supreme Court Debates;Sep2013, Vol. 16 Issue 6, p28 

    An excerpt from the Amicus Curiae Brief for Respondents that was submitted to the U.S. Supreme Court in March 2013, involving the Pharmaceutical Research and Manufacturers of America (PhRMA), is presented.

  • Domino Effect. Acosta, Ted // Pharmaceutical Executive;May2006 Supplement, p20 

    The article reports on global compliance to the codes of conduct for sales and marketing in the pharmaceutical industry. The Pharmaceutical Research and Manufacturers of America(PhRMA) and the European Federation of Pharmaceutical Industries and Associations have issued new codes of conduct as a...

  • Dermatologists debate ethics of in-office dispensing. Nash, Karen // Dermatology Times;Mar1999, Vol. 20 Issue 3, p80 

    Reports on the debate on the ethical aspects of United States dermatologists' sale of nonprescription health-related products in their offices. American Society of Plastic and Reconstructive Surgeons' defense of the ethical nature of the practice; In-office dispensing as a potential threat to...

  • Court rebuffs PhRMA on 340B drug policy.  // AHA News;8/29/2014, Vol. 50 Issue 17, p1 

    The article reports on the decision of a U.S. federal judge to reject requests from Pharmaceutical Research and Manufacturers of America (PhRMA) to invalidate a rule concerning orphan drugs in the 340B drug discount program in the country.

  • Free gifts to health care professionals now a no-no. BASSETT, ELIZABETH // Fort Worth Business Press;1/26/2009, Vol. 21 Issue 3, p21 

    The article reports on the revision of Pharmaceutical Research and Manufacturers of America's voluntary Code on Interactions with Healthcare Professionals which prohibits handing out non-educational reminders to health care professionals. The reason behind the revision is the tendency of such...

  • Doctors value details, says PhRMA-sponsored survey. M. A. // Medical Marketing & Media;May2011, Vol. 46 Issue 5, p15 

    The article reports on the findings of the survey sponsored by the Pharmaceutical Research and Manufacturers of America (PhRMA) which revealed that 80 percent of physicians see pharmaceutical companies to acquire information on prescription drugs in the U.S.

  • Drug industry group disputes NY Times drug price report. FREDERICK, JIM // Drug Store News;12/14/2009, Vol. 31 Issue 15, p50 

    The article reports on the angry reaction of the organization, Pharmaceutical Research and Manufacturers of America (PhRMA) to a report in the newspaper "New York Times," that wholesale pharmaceutical prices in the U.S. are rising rapidly, despite a drop in overall consumer prices. Senior vice...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics